A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis
NCT00646035
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
75
Enrollment
INDUSTRY
Sponsor class
Conditions
End Stage Renal Disease
Interventions
DRUG:
paricalcitol capsules
Sponsor
Abbott